Nuclear Medicine

Our research focuses on advanced molecular imaging in oncology, neurodegenerative disorders, and cardiovascular disease, integrating radiomics, quantitative imaging biomarkers, and AI-driven analytical methods. We also investigate radioligand therapy for targeted cancer treatment. Using state-of-the-art SPECT-CT, PET-CT, and diverse radiolabeled tracers, we study pathophysiological mechanisms to enhance diagnosis, staging, prognosis, therapy selection, and overall clinical decision-making. These integrated approaches aim to improve precision imaging and support personalized clinical care.

Principal research lines

• Molecular Imaging in Cancer (Camacho Marti, Valle; Fernandez Leon, Alejandro).
• Brain Imaging in Neurodegenerative Disorders (Camacho Marti, Valle).
• Cardiovascular Inflammation: (Fernandez Leon, Alejandro; Velasco Nuño, Monica).
• Infectious bone pathology: (Velasco Nuño, Monica).
• Cardiac Amyloidosis: (Flotats Giralt, Albert; Velasco Nuño, Monica).
• Artificial Intelligence in Image Reading: (Flotats Giralt, Albert; Velasco Nuño, Monica).

Scientific Challenges

• Innovative Technologies in Diagnosis and Therapy.
• Molecular Imaging of Diseases.
• Integration of Artificial Intelligence Tools in Research and Clinical Practice.

Contact

Albert Flotats
aflotats@santpau.cat